Literature DB >> 24255642

Neuroendocrine dysplasia combined in a tubular adenoma of rectum: a case report.

So-Young Lee1, Dae-Yong Hwang, Tae Sook Hwang, Wan-Seop Kim, So Dug Lim, Wook Youn Kim, Se-Hun Kim, Hye Seung Han.   

Abstract

Entities:  

Year:  2013        PMID: 24255642      PMCID: PMC3831001          DOI: 10.4132/KoreanJPathol.2013.47.5.495

Source DB:  PubMed          Journal:  Korean J Pathol        ISSN: 1738-1843


× No keyword cloud information.
  8 in total

Review 1.  Gastrointestinal endocrine cells and carcinoids. Histogenetic and pathogenetic considerations.

Authors:  T N Moyana
Journal:  Pathol Annu       Date:  1995

2.  Microcarcinoids in large intestinal adenomas.

Authors:  Melissa Pulitzer; Ruliang Xu; Arief A Suriawinata; Jerome D Waye; Noam Harpaz
Journal:  Am J Surg Pathol       Date:  2006-12       Impact factor: 6.394

3.  Enteroendocrine cell hyperplasia, carcinoid tumours and adenocarcinoma in long-standing ulcerative colitis.

Authors:  A Gledhill; P A Hall; J P Cruse; D J Pollock
Journal:  Histopathology       Date:  1986-05       Impact factor: 5.087

Review 4.  Carcinoid tumors and the mixed (composite) glandular-endocrine cell carcinomas.

Authors:  K Lewin
Journal:  Am J Surg Pathol       Date:  1987       Impact factor: 6.394

5.  Resolving microcarcinoids in ulcerative colitis: report of a case.

Authors:  Paul Quinn; Cameron F E Platell
Journal:  Dis Colon Rectum       Date:  2004-03       Impact factor: 4.585

6.  Neuroendocrine cell hyperplasia in colonic tissue used for long term augmentation cystoplasty.

Authors:  K Oien; M Akyol; G Lindop
Journal:  J Clin Pathol       Date:  1998-03       Impact factor: 3.411

7.  Neuroendocrine neoplasms arising in inflammatory bowel disease: a report of 14 cases.

Authors:  J E Sigel; J R Goldblum
Journal:  Mod Pathol       Date:  1998-06       Impact factor: 7.842

8.  Neuroendocrine cells in colorectal adenomas.

Authors:  H F Van den Ingh; L J Van den Broek; A A Verhofstad; F T Bosman
Journal:  J Pathol       Date:  1986-03       Impact factor: 7.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.